Merck will host a conference to discuss long-term environmental, social, and governance priorities
Merck & Co., Inc.
The long-term ESG strategies of Merck will be covered at the company's virtual investor event. The event will take place on February 23 at 10:00 a.m. Eastern Time. Priority areas include employee well-being, environmental sustainability, ethics, and values.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, provided additional details today of the company’s virtual Investor Event in which its senior management team will discuss Environmental, Social & Governance (ESG) priorities. The event, scheduled for Wednesday, February 23 at 10:00 a.m. EST, will discuss the company’s long-term ESG strategies. These strategies focus on the company’s four ESG priority areas: Access to Health, Employees, Environmental Sustainability and Ethics & Value.
Investors, analysts, members of the media and the general public are invited to listen to the webcast of the presentation at Merck & Co., Inc. ESG Event - Merck.com. There will be a Q&A panel session with the senior management team following the prepared remarks. To submit a question in advance of the webcast, please send to [email protected].
About Merck: For over 130 years, Merck, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information,
visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Source: Merck news
